Verve Therapeutics Inc
VERV
Market Cap$520.11M
Close$
$1.29
79.1% downside
Current Fair Value
79.1% downsideOvervalued by 79.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $520.11 Million |
|---|---|
| Enterprise Value | $-28,931,085.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.12 |
| Beta | 0.0 |
| Outstanding Shares | 83,619,279 |
| Avg 30 Day Volume | 1,643,169 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.6 |
|---|---|
| PEG | -14.7 |
| Price to Sales | - |
| Price to Book Ratio | 0.88 |
| Enterprise Value to Revenue | -2.46 |
| Enterprise Value to EBIT | 0.13 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -2.59 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
ESG Score
No data
About Verve Therapeutics Inc
63 employees